We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The JCVI has issued new advice regarding the AstraZeneca COVID-19 vaccine after reports of extremely rare blood clots.
Face coverings in schools and colleges are to remain in place at start of summer term, following an ongoing review of the evidence and data
New chief executive marked her first day with a visit to Colindale laboratories in North London, accompanied by Health Secretary Matt Hancock.
JCVI recommends that adults living with adults who are immunosuppressed should be prioritised for the COVID-19 vaccine.
Analysis carried out by Public Health England suggests that the COVID-19 vaccination programme prevented 6,100 deaths in England up to the end of February 2021.
New findings from Public Health England have shown that an estimated 75.8% of 70 to 84 year old blood donors had antibodies against COVID-19 by early March.
The JCVI has advised the government to prioritise people experiencing homelessness, including those sleeping rough, for the coronavirus (COVID-19) vaccine.
Step One of the roadmap begins tomorrow with pupils returning to face-to-face education.
New data show both Pfizer-BioNTech and Oxford-AstraZeneca vaccines significantly reduce severe COVID-19 in older adults.
The Joint Committee on Vaccination and Immunisation (JCVI) has considered the evidence for Phase 2 of the UK’s COVID-19 vaccination programme.
JCVI has advised the government to invite all people on the GP Learning Disability Register for COVID-19 vaccination.
A study conducted by Public Health England (PHE) estimates that 17.8% of university students in England had COVID-19 antibodies.
PHE has today published the first independent analysis in the UK showing the Pfizer-BioNTech vaccine is effective against COVID-19 from the first dose.
Regular updates on cold weather and how to stay well during low temperatures.
NERVTAG has named one additional SARS-CoV-2 Variant Under Investigation and one additional Variant of Concern.
More than one third of people aged 80 and over in England have received at least one dose of the coronavirus (COVID-19) vaccine as of 10 January.
Study finds past coronavirus (COVID-19) infection provides some immunity for at least 5 months, but people may still carry and transmit the virus.
Over 80% of those aged 65 and over in England have received the flu vaccine so far this year – the highest uptake ever achieved.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued its advice on the AstraZeneca COVID-19 vaccine.
Public Health England (PHE) has confirmed that lateral flow devices (LFDs) used in mass testing can detect the new COVID-19 variant.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).